Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.
Thanks to the work of NEI scientists and grantees, we’re constantly learning new information about the causes and treatment of vision disorders. Get the latest updates about their work — along with other news about NEI.
Nerve cells that normally are not light sensitive in the retinas of blind mice can respond to light when a green algae protein called channelrhodopsin-2 (ChR2) is inserted into the cell membranes according to a National Institutes of Health...
A clinical trial funded by the National Eye Institute (NEI), part of the National Institutes of Health (NIH), has concluded that a single dose of azithromycin taken by mouth after surgery reduces by one-third the recurrence of a vision-threatening...
The National Institutes of Health (NIH) today announced the signing of a United States-India Statement of Intent for collaboration on expansion of vision research.
In comparisons using selected vision screening tests, trained nurses and lay people were able to correctly identify up to 68 percent of children with at least one of the most prevalent vision disorders of childhood: amblyopia (lazy eye), strabismus...
Glaucoma is an eye disease usually associated with an increased fluid pressure inside the eyes that damages the optic nerve, leading to vision loss or even blindness.
Surprising results from a nationwide clinical trial show that many children age seven through 17 with amblyopia (lazy eye) may benefit from treatments that are more commonly used on younger children.
NEI researchers have concluded that taking a recommended 400 international units (IU) of vitamin E each day, as part of the AREDS formulation, does not increase the risk of death of persons at risk for advanced AMD.
For most patients with abnormal blood vessels in the eye, either as a delayed complication from a fungus infection called histoplasmosis or from unknown causes, surgery will not likely improve vision.
Vision does not improve substantially for patients with age-related macular degeneration (AMD) who undergo surgery to remove lesions of new blood vessels, scar tissue, or possible bleeding beneath the retina.